Clinical Trial: Study of How Mitapivat Affects Midazolam Blood Levels in Healthy Participants
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy Participants
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-label, One-Sequence Crossover Study to Assess the Effect of Mitapivat on the Pharmacokinetics of the CYP3A Substrate (Midazolam) in Healthy Participants
Brief Summary:
The primary purpose of this study is to assess the effect of mitapivat on the single oral dose pharmacokinetics (PK) of midazolam in healthy participants.
Read more